In November 2025, the European Commission published the Delegated Regulation (EU) 2025/2551 on supplementing Regulation (EU) 2023/956 (CBAM) by specifying the conditions for granting accreditation to verifiers, for the control and oversight of accredited verifiers, for the withdrawal of accreditation and for mutual recognition and peer evaluation of accreditation bodies.
According to Regulation (EU) 2023/956 (CBAM) and Delegated Regulation 2025/2551, a verifier located in the EU shall apply for accreditation to its National Accreditation Body. Verifiers established in a third country shall request a National Accreditation Body from the EU that provides accreditation under EU CBAM to grant accreditation.
Where the National Accreditation Body provides accreditation services under EU CBAM but is unable to carry out the accreditation of a verifier established in a third country, the National Accreditation Body – with the support of EA – will help those verifiers to find a National Accreditation Body that can provide accreditation in the third country concerned.
For this purpose, EA is publishing a directory of National Accreditation Bodies that intend to offer accreditation of verifiers for EU CBAM. You can find this directory here.
For more information, please see the News from 27 January 2026 here.
In November 2025, the Implementing Regulation (EU) 2025/2358 laying down rules on certification schemes, certification bodies, and audits under Regulation (EU) 2024/3012 has been published in the Official Journal of the EU.
The references of the “EN ISO 20387:2020 Biotechnology – Biobanking – General requirements for biobanking” are published in the Official Journal of the EU as of 23 February 2026.
